logo
ANNEX PHARMACEUTICALS PRIVATE LIMITED

ACTIVE

PRIVATE COMPANY

Annex Pharmaceuticals Private Limited is a Private Company incorporated on 2005. It is classified as Non-govt company as a Company limited by Shares and is registered at Registrar of Companies, RoC-Patna. Its authorized share capital is Rs. 200000.0 and its paid up capital is Rs. 100000.0. It is involved in Trading, trading Annex Pharmaceuticals Private Limited's Annual General Meeting (AGM) was last held on 2020-11-20 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2020-03-31 Annex Pharmaceuticals Private Limited's Corporate Identification Number is (CIN) U51397BR2005PTC011513 and its registration number is 11513. Its Email address is annexpharma@gmail.com and its registered address is SHOP NO. 3 UPPER GOURI SHANKARCOMPLEX PLOT NO-DS 23 LOHIA NAGAR KANKARBAGH PATNA-20 NAGAR KANKARBAGH PATNA BR 000000 IN


Basic Info

STATUS

ACTIVE

TYPE

PRIVATE COMPANY

PAID UP CAPITAL

₹1.00 lakh(s)

ADDRESS

SHOP NO. 3 UPPER GOURI SHANKARCOMPLEX PLOT NO-DS 23 LOHIA NAGAR KANKARBAGH PATNA-20 NAGAR KANKARBAGH PATNA BR 000000 IN


Registrations

CIN

U51397BR2005PTC011513


Relationships

MANJU KUMARI

Director

Appointed on: 05 Aug 2005
15 Year(s) 6 Month(s)

RAJEEV

Director

Appointed on: 05 Aug 2005
15 Year(s) 6 Month(s)

Get a

of
ANNEX PHARMACEUTICALS PRIVATE LIMITED for free now!

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources

Used by leading banks and financial institutions in India

Used by leading banks and financial institutions in India

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Leverage these reports for credit decisioning, competitor analysis, and supplier/vendor evaluation

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources

Comprehensive report with insights built on 50+ risk parameters and 2000+ public data sources